RxDoctor Payments Data

Ahmad Abrishamchian, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Harrisburg, PANPI 1518028596

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $39,800 of the $51,806 with a category attached, or 76.8%. Medtronic accounts for 81.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $17,296 and has fallen 97.4% since, to $449 in 2025.

$51,806in general payments, 2019–2025

Across 154 payments — averaging $336.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$42K
  • Atricure, Inc.$5K
  • Edwards Lifesciences$4K
  • Inion Inc$90
  • Abbott$29
  • Novus Surgical Consultants$27
  • plus $17 from 1 others
$4,030in research payments, 2019–2025

Across 8 payments — averaging $503.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Atricure, Inc.$4K

What the payments were for

  • Speaking & faculty fees$39,80077%
  • Travel & lodging$6,40512%
  • Food & beverage$5,60111%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)45$42,397
Atricure, Inc.77$4,829
Edwards Lifesciences28$4,418
Inion Inc1$90
Abbott1$29
Novus Surgical Consultants1$27
Getinge USA Sales, LLC1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$51,806 in reported general payments places this provider in the 85th percentile of 314 thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$166,272
Medicare patients
91
Services billed
199

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Harrisburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →